What can we expect here? SLT was tipped as a $2 stock around 12 months ago by one of the major brokerage houses, should we keep buying anticipating the major upward shift is to come soon?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%